Zealand Pharma — Februar 2022
-
Ungeee, vi nåede desværre ikke kurs 300 i denne omgang, og i den forbindelse vel ganske betryggende set i perspektiv, at VH ligesom mange af os andre heller ikke solgte ud ved kurs-næsten-300?! Tror nu alligevel fortsat, VH har en strategi, der går langt mere i retning af salg/frasalg end egentlig value inkl. muligt udbytte m.m.?!, god weekend
-
"I have been very impatiently waiting for this device! Just look at some of these comments by people who have worn it in the trials. This could make life so much better!!! Please God, please let this come quickly!!!"
"My son wore the iLet in October 2020 & April-July 2021. Oh, how we want to be first in line to get it! It was miraculous."
-
Gadbois det var et meget beskedent kursmål. Hvad bygger du det på. Tror du at Glepaglutide fejler. Eller mener du ikke at Zealand er mere værd selv med Glepaglutide godkendt/på marked. Husk at Shire i 2015 betalte 5,2 mia. USD for NPS Pharmaceutical, hvis hovedprodukt ”Gattex” var netop mod SBS.
-
Måske en ældre Storm P. kan hjælpe lidt på humøret..., Pessimisten til optimisten: "nu kan det da ikke blive meget værre?!" - optimisten til pessimisten: " ork jo, det kan det da sagtens!?!"
-
tak
-
Der er lige her Swingtrader.
-
tak chef:)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind